Literature DB >> 28659395

Cellular and molecular mechanisms of asthma and COPD.

Peter J Barnes1.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) both cause airway obstruction and are associated with chronic inflammation of the airways. However, the nature and sites of the inflammation differ between these diseases, resulting in different pathology, clinical manifestations and response to therapy. In this review, the inflammatory and cellular mechanisms of asthma and COPD are compared and the differences in inflammatory cells and profile of inflammatory mediators are highlighted. These differences account for the differences in clinical manifestations of asthma and COPD and their response to therapy. Although asthma and COPD are usually distinct, there are some patients who show an overlap of features, which may be explained by the coincidence of two common diseases or distinct phenotypes of each disease. It is important to better understand the underlying cellular and molecular mechanisms of asthma and COPD in order to develop new treatments in areas of unmet need, such as severe asthma, curative therapy for asthma and effective anti-inflammatory treatments for COPD.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  cytokines/2; inflammation; inflammatory cells

Mesh:

Substances:

Year:  2017        PMID: 28659395     DOI: 10.1042/CS20160487

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  93 in total

1.  Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease.

Authors:  Evelyn Tsantikos; Maverick Lau; Cassandra Mn Castelino; Mhairi J Maxwell; Samantha L Passey; Michelle J Hansen; Narelle E McGregor; Natalie A Sims; Daniel P Steinfort; Louis B Irving; Gary P Anderson; Margaret L Hibbs
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

2.  Novel insights into the effects of cigarette smoke on the airway epithelial surface-lessons learned at the European Respiratory Society International Congress 2018 in Paris.

Authors:  Gimano D Amatngalim; Rodolfo Paula Vieira; Silke Meiners; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  Cigarette smoke-induced reduction of C1q promotes emphysema.

Authors:  Xiaoyi Yuan; Cheng-Yen Chang; Ran You; Ming Shan; Bon Hee Gu; Matthew C Madison; Gretchen Diehl; Sarah Perusich; Li-Zhen Song; Lorraine Cornwell; Roger D Rossen; Rick Wetsel; Rajapakshe Kimal; Cristian Coarfa; Holger K Eltzschig; David B Corry; Farrah Kheradmand
Journal:  JCI Insight       Date:  2019-05-21

Review 4.  Obstructive lung diseases and risk of rheumatoid arthritis.

Authors:  H Maura Friedlander; Julia A Ford; Alessandra Zaccardelli; Alexsandra V Terrio; Michael H Cho; Jeffrey A Sparks
Journal:  Expert Rev Clin Immunol       Date:  2020-01-06       Impact factor: 4.473

Review 5.  Heterotrimeric Gq proteins as therapeutic targets?

Authors:  Evi Kostenis; Eva Marie Pfeil; Suvi Annala
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

6.  Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.

Authors:  Amel Ben Anes; Hela Ben Nasr; Abdelhamid Garrouch; Sarra Bennour; Sarra Bchir; Mohamed Hachana; Mohamed Benzarti; Zouhair Tabka; Karim Chahed
Journal:  Mol Cell Biochem       Date:  2017-12-12       Impact factor: 3.396

Review 7.  What will Happen in the World of COPD 2030?

Authors:  Richard E K Russell; Mona Bafadhel
Journal:  Turk Thorac J       Date:  2019-07-30

Review 8.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

9.  Theophylline and dexamethasone in combination reduce inflammation and prevent the decrease in HDAC2 expression seen in monocytes exposed to cigarette smoke extract.

Authors:  Xue-Jiao Sun; Zhan-Hua Li; Yang Zhang; Xiao-Ning Zhong; Zhi-Yi He; Ji-Hong Zhou; Si-Ning Chen; Yuan Feng
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

10.  Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice.

Authors:  Giovanna De Cunto; Vincenzo Brancaleone; Maria Antonietta Riemma; Ida Cerqua; Valentina Vellecco; Giuseppe Spaziano; Eleonora Cavarra; Barbara Bartalesi; Bruno D'Agostino; Giuseppe Lungarella; Giuseppe Cirino; Monica Lucattelli; Fiorentina Roviezzo
Journal:  Br J Pharmacol       Date:  2019-11-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.